IL-6 ASSOCIATED WITH GRADING OF CYTOKINE RELEASE SYNDROME AND MANAGEMENT TIME OF TOCILIZUMAB AFTER CAR-T CELL THERAPY
EHA Library, Heng Mei, 266839
EVEROLIMUS WITH DHAP (DEXAMETHASONE, HIGH-DOSE ARAC, CISPLATINUM) IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA: A RANDOMIZED, PLACEBO-CONTROLLED PHASE I/II TRIAL (HD-R3I)
EHA Library, Bastian von Tresckow, 266857
CONTEMPORARY TREATMENT PATTERNS AND RESPONSE IN RELAPSE/REFRACTORY CUTANEOUS T-CELL LYMPHOMA (CTCL) IN CLINICAL PRACTICE IN FRANCE, GERMANY ITALY, SPAIN AND THE UNITED KINGDOM
EHA Library, Tim Illidge, 266873
A SURVEY OF PRACTICE RELATING TO THE PREVENTION AND TREATMENT OF INVASIVE FUNGAL INFECTIONS IN UK HAEMATOLOGY CENTRES
EHA Library, Nick Duncan, 266889
SAFETY AND UTILIZATION OF MIDLINE CATHETERS VERSUS TUNNELED CENTRAL VENOUS CATHETERS IN THE MANAGEMENT OF ACUTE MYELOID LEUKEMIA PATIENTS: A SINGLE CENTER EXPERIENCE.
EHA Library, Hélène Gardeney, 266905
FOLLICULAR HELPER T-CELLS FORM MUTUALLY SUPPORTIVE INTERACTIONS WITH FOLLICULAR LYMPHOMA B-CELLS THAT MAY SUPPORT TUMOUR GROWTH
EHA Library, Elizabeth PHILLIPS, 266921
CDCA7 REGULATES LYMPHOMA CELLS MIGRATION, INVASIVENESS AND THEIR MICROTUBULE AND ACTOMYOSIN CYTOSKELETONS DYNAMICS.
EHA Library, Carla Martín-Cortázar, 266937
DISCREPANCE OF ALLELIC BURDEN CHANGES AND CLINICAL RESPONSE IN PATIENTS WITH HIGHER RISK MYELODYSPLASTIC SYNDROME TREATED WITH HYPOMETHYLATING AGENTS
EHA Library, Joon Ho MOON, 266953
DISSECTING THE BONE MARROW IMMUNE MICROENVIRONMENT IN THE COMPLETE SPECTRUM OF MONOCLONAL GAMMOPATHIES: POTENTIAL IMPLICATIONS IN DISEASE PATHOGENESIS
EHA Library, Noemi Puig, 266969
ELOTUZUMAB PLUS POMALIDOMIDE AND DEXAMETHASONE FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: EFFICACY RESULTS AFTER ADDITIONAL FOLLOW-UP OF THE PHASE 2, RANDOMIZED ELOQUENT-3 STUDY
EHA Library, Paul Richardson, 266987
CARFILZOMIB AS PART OF A DOSE DENSE, LESS DOSE INTENSE TOTAL THERAPY APPROACH FOR HIGH RISK MYELOMA
EHA Library, Frits van Rhee, 267003
OUTCOME IN TRANSPLANT ELIGIBLE PATIENTS WITH MULTIPLE MYELOMA IN LATIN AMERICA. AN INTERNATIONAL STUDY OF GELAMM.
EHA Library, Camila Peña, 267019
POMALIDOMIDE-BASED TREATMENT IN RELAPSED REFRACTORY MULTIPLE MYELOMA: ANALYSIS OF BASELINE CHARACTERISTICS AND SAFETY PROFILE OF PATIENTS WHO DIED IN THE EUROPEAN POST APPROVAL SAFETY STUDY
EHA Library, Barbara Gamberi, 267035
THE EFFECT OF HYDROXYUREA ON DNA METHYLATION AND GENE EXPRESSION IN POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA.
EHA Library, Stephania CONTRERAS, 267068
EARLY RESULTS OF A PHASE II STUDY OF COMBINED RUXOLITINIB AND THALIDOMIDE IN PATIENTS WITH MYELOFIBROSIS
EHA Library, Raajit Rampal, 267084
NOVEL ADAMTS13 MUTATIONS IN A PATIENT OF INHERITED THROMBOTIC THROMBOCYTOPENIC PURPURA
EHA Library, Li Zhou, 267101
QUALITY OF LIFE IN PATIENTS UNDERGOING CHIMERIC ANTIGEN RECEPTOR (CAR) - T CELL THERAPY VS. AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANT FOR HEMATOLOGIC MALIGNANCIES
EHA Library, Surbhi Sidana, 267118
MILD COGNITIVE IMPAIRMENT, HYPOALBUMINEMIA, HIGH CRP AND GASTRO-INTESTINAL ULCER: 4 MARKERS OF FRAILTY WHICH IDENTIFY OLDER PATIENTS WITH MALIGNANT HEMOPATHIES WHO DON’T BENEFIT FROM CHEMOTHERAPY
EHA Library, Vincent Thibaud, 267134
KD025-208: A PHASE 2A TRIAL OF KD025 FOR PATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD) - UPDATED SAFETY AND EFFICACY
EHA Library, Amandeep Salhotra, 267150
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION CAN OVERCOME THE POOR OUTCOME OF ADULT PH(+) ACUTE LYMPHOBLASTIC LEUKEMIA -- ON BEHALF OF TAIWAN SOCIETY OF BLOOD AND MARROW TRANSPLANTATION
EHA Library, Tran-Der Tan, 267167
UNCOUPLING INK PROTEINS FROM CDK4/CDK6 IN HSCS - UNCOUPLING PROLIFERATION FROM SENESCENCE
EHA Library, Michaela Prchal-Murphy, 267184
BONE MARROW TRANSPLANT AND VENOUS THROMBOEMBOLIC DISEASE, A POTENTIALLY PREVENTABLE CAUSE OF MORTALITY AND MORBILITY.
EHA Library, Estefanía Morente Constantín, 267200
HIGH-THROUGHPUT IMAGING ANALYSIS FOR DRUG COMBINATION EFFICACY AND SPECIFICITY IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA
EHA Library, Edward Law, 267216
HIV INTEGRASE INHIBITOR MK-2048 INDUCES APOPTOSIS IN HTLV-1 INFECTED CELLS THROUGH THE UPR ACTIVATION.
EHA Library, Emi Ikebe, 267233
INOTUZUMAB OZOGAMICIN (INO) TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA (R/R ALL): OUTCOMES OF PATIENTS TREATED IN SALVAGE ONE WITH A LONG DURATION OF FIRST REMISSION
EHA Library, Matthias Stelljes, 267250
A NOVEL FAST CD19 CAR-T CELLS: RAPID AND EFFICIENT TREATMENT FOR REFRACTORY B-ALL(BP-CML)
EHA Library, Xi Zhang, 267266
THE ROLE OF STAT3 ISOFORMS IN ACUTE MYELOID LEUKEMIA
EHA Library, Dagmar Stoiber, 267283
SINGLE CELL SIGNALING PHARMACODYNAMICS IN A PHASE 1B CLINICAL TRIAL OF THE AXL INHIBITOR BEMCENTINIB IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME
EHA Library, Oda Helen Eck, 267300
GRANULOCYTES AND MONO-NUCLEAR CELLS FROM PATIENTS WITH MYELOPROLIFERATIVE DISORDERS HARBOUR PERSISTENT EVIDENCE OF DNA DAMAGE AND TP53 PATHWAY ACTIVATION THAT CORRELATES WITH JAK-STAT ACTIVATION
EHA Library, Andrew INNES, 267052
SINTILIMAB FOR RELAPSED/REFRACTORY (R/R) EXTRANODAL NK/T CELL LYMPHOMA (ENKTL): A MULTICENTER, SINGLE-ARM, PHASE 2 TRIAL (ORIENT-4)
EHA Library, L Fan, 267453
SUBCUTANEOUS DARATUMUMAB + CYCLOPHOSPHAMIDE, BORTEZOMIB, AND DEXAMETHASONE (CYBORD) IN PATIENTS WITH NEWLY DIAGNOSED AMYLOID LIGHT CHAIN (AL) AMYLOIDOSIS: UPDATED SAFETY RUN-IN RESULTS OF ANDROMEDA
EHA Library, Raymond L. Comenzo, 267458
A PHASE II STUDY OF SELINEXOR PLUS CYTARABINE AND IDARUBICIN IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
EHA Library, Walter Fiedler, 267463
IN SEARCH OF THE RESIDUAL LEUKAEMIC CLONE IN CHRONIC MYELOID LEUKAEMIA PATIENTS IN TREATMENT-FREE REMISSION
EHA Library, Ilaria Stefania Pagani, 267468
DEFECTIVE GLYCOLYSIS IN BONE MARROW ENDOTHELIAL CELLS OF PATIENTS WITH POOR GRAFT FUNCTION POST-ALLOTRANSPLANT IDENTIFIES A POTENTIAL THERAPEUTIC STRATEGY
EHA Library, Zhong-Shi Lyu, 267477
CD19+ RELAPSE POST CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IS DETERMINED BY T CELL FITNESS
EHA Library, Robin Sanderson, 267481
GAIN-OF-FUNCTION MUTATIONS IN PIEZO1 DIRECTLY IMPAIR HEPATIC IRON METABOLISM BY ALTERATIONS OF BMP/SMADS PATHWAY
EHA Library, Immacolata Andolfo, 267486
ASSESSMENT OF BLEEDING SEVERITY IN THROMBOCYTOPENIC PATIENTS UNDERGOING MINOR INVASIVE PROCEDURES IS HIGHLY VARIABLE, A SYSTEMATIC REVIEW
EHA Library, Frank van Baarle, 267491
LOCAL INTERFERON-ALPHA DELIVERY INTO THE MYELOMA MICROENVIRONMENT BY GENE-ENGINEERED AUTOLOGOUS STEM CELL TRANSPLANTATION
EHA Library, Gabriele Antonarelli, 267495
TNF-ALPHA PROMOTES CLONAL EXPANSION OF KIT D816V+ CELLS IN SYSTEMIC MASTOCYTOSIS
EHA Library, Georg Greiner, 267051
TIPIFARNIB IN RELAPSED OR REFRACTORY ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA (AITL) AND CXCL12+ PERIPHERAL T-CELL LYMPHOMA (PTCL): PRELIMINARY RESULTS FROM AN OPEN-LABEL, PHASE 2 STUDY
EHA Library, Thomas Witzig, 267452
EFFICACY OF DARATUMUMAB + BORTEZOMIB/THALIDOMIDE/DEXAMETHASONE (D-VTD) IN TRANSPLANT-ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA BASED ON MINIMAL RESIDUAL DISEASE STATUS: ANALYSIS OF CASSIOPEIA
EHA Library, Hervé Avet-Loiseau, 267457
RESULTS OF ASTRAL-1 STUDY, A PHASE 3 RANDOMIZED TRIAL OF GUADECITABINE (G) VS TREATMENT CHOICE (TC) IN TREATMENT NAÏVE ACUTE MYELOID LEUKEMIA (TN-AML) NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY (IC)
EHA Library, Pierre Fenaux, 267462
COMBINATION OF ASCIMINIB PLUS NILOTINIB (NIL) OR DASATINIB (DAS) IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA (CML): RESULTS FROM A PHASE 1 STUDY
EHA Library, Sam Kew, 267467
APOPTOTIC MESENCHYMAL STROMAL CELLS INDUCE PROSTAGLANDIN E2 IN MONOCYTES: IMPLICATIONS FOR THE MONITORING OF MESENCHYMAL STROMAL CELL ACTIVITY
EHA Library, Tik Shing Cheung, 267476
VALIDATION OF A NOVEL MECHANISM OF ACTION FOR TREATMENT OF CCR7+ HEMATOLOGICAL MALIGNANCIES WITH FIRST-IN-CLASS ANTIBODY CAP-100
EHA Library, Carlos Cuesta-Mateos, 267480
THE COMPLEXITY OF GENOTYPE-PHENOTYPE CORRELATIONS IN HEREDITARY SPHEROCYTOSIS: A COHORT OF 95 PATIENTS.
EHA Library, Annelies van Vuren, 267485
DEVELOPMENT OF HUMANIZED MOUSE MODEL FOR STUDYING MOTHER TO CHILD HTLV-1 TRANSMISSION AND PREVENTION WITH HTLV-1 ANTIBODY TREATMENT.
EHA Library, Takuo Mizukami, 267490
A COMBINATORIAL RECEPTOR STRATEGY TO IMPROVE MULTIPLE MYELOMA THERAPY WITH CHIMERIC ANTIGEN RECEPTOR-ENGINEERED T LYMPHOCYTES
EHA Library, Afroditi Katsarou, 267494
EMERGING CLINICAL ACTIVITY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY (AB), IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (B-NHL)
EHA Library, Rajat Bannerji, 267451
EFFICACY OF QUADRUPLET KCRD (CARFILZOMIB, CYCLOPHOSPHAMIDE, LENALIDOMIDE AND DEXAMETHASONE) INDUCTION FOR NEWLY DIAGNOSED MYELOMA PATIENTS: ANALYSIS OF THE MYELOMA XI STUDY BY MOLECULAR RISK
EHA Library, Charlotte PAWLYN, 267456
THE FIRST-IN-CLASS ANTI-CD47 ANTIBODY HU5F9-G4 IS ACTIVE AND WELL TOLERATED ALONE OR IN COMBINATION WITH AZACITIDINE IN AML AND MDS PATIENTS: INITIAL PHASE 1B RESULTS
EHA Library, David Sallman, 267461
COMBINATION THERAPY USING ASCIMINIB PLUS IMATINIB (IMA) IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA (CML): RESULTS FROM A PHASE 1 STUDY
EHA Library, Sam Kew, 267466
INTESTINAL STEM CELL DAMAGE IN GRAFT-VERSUS-HOST DISEASE IS PRIMARILY CAUSED BY T-CELL DERIVED INTERFERON-GAMMA
EHA Library, Suze Jansen, 267475
COMBINED GENE PANEL SEQUENCING AND EKTACYTOMETRY - THE NEXT GENERATION OF RED CELL DIAGNOSTICS
EHA Library, Nicholas Parkin, 267484
PRECLINICAL EVALUATION OF THE PRESERVATION OF RED BLOOD CELL CONCENTRATES IN HYPOXIA BY HYPOXIC STORAGE TECHNOLOGY FOR TRANSFUSION IN SICKLE CELL DISEASE.
EHA Library, Laura Bencheikh, 267489
THE FIRST-IN-CLASS ANTI-CD47 ANTIBODY HU5F9-G4 WITH RITUXIMAB INDUCES DURABLE RESPONSES IN RELAPSED/REFRACTORY DLBCL AND INDOLENT LYMPHOMA: INTERIM PHASE 1B/2 RESULTS
EHA Library, Mark Roschewski, 267450
CARFILZOMIB LENALIDOMIDE DEXAMETHASONE (KRD) WITH OR WITHOUT TRANSPLANTATION IN NEWLY DIAGNOSED MYELOMA (FORTE TRIAL): EFFICACY ACCORDING TO RISK STATUS
EHA Library, Francesca Gay, 267455
SAFETY AND CLINICAL ACTIVITY OF AMV564, A CD33/CD3 T-CELL ENGAGER, IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML): UPDATED RESULTS FROM THE PHASE 1 FIRST-IN-HUMAN TRIAL
EHA Library, Peter Westervelt, 267460
OPTIMIZATION OF TKI TREATMENT IN ELDERLY PATIENTS WITH PH+ CHRONIC MYELOID LEUKEMIA AND STABLE MR3.0 OR MR4.0: 1ST YEAR RESULTS OF THE ITALIAN MULTICENTRIC PHASE-III RANDOMIZED OPTKIMA STUDY
EHA Library, Michele malagola, 267465
DISSECTING THE ROLE OF CXCL4 IN PRIMARY MYELOFIBROSIS
EHA Library, Hélène Gleitz, 267472
SUCCESSFUL TREATMENT OF INTESTINAL GRAFT-VERSUS-HOST DISEASE WITH FECAL MICROBIOTA TRANSPLANTATION
EHA Library, Yannouck van Lier, 267474
SYNTHETIC LETHAL EFFECTS OF DUAL BCR AND PARP INHIBITION IN PROLIFERATIVE DEL(11Q) CLL CELLS IN THE PRESENCE OF STROMAL STIMULATION
EHA Library, Miguel Quijada-Álamo, 267479
EVIDENCE BASED USE OF ERYTRHOPOIETIN IN PATIENTS WITH AUTOIMMUNE HEMOLYTIC ANEMIA: A MULTICENTER INTERNATIONAL STUDY
EHA Library, Bruno Fattizzo, 267483
LONG TERM INHIBITION OF COMPLEMENT C1S IN PATIENTS WITH COLD AGGLUTININ DISEASE: RESULTS FROM A NAMED PATIENT PROGRAM
EHA Library, Georg Gelbenegger, 267488
A NEW MEMBRANE-BOUND IL-21/4-1BBL-EXPANDED NK PRODUCT EXHIBITS ACTIVITY AGAINST ACUTE MYELOID LEUKEMIA ACTIVITY IN VIVO
EHA Library, Xiangyu Zhao, 267493
PHASE 1/2 TRIAL OF ACALABRUTINIB PLUS PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Thomas Witzig, 267449
CURATIVE STRATEGY (GEM-CESAR) FOR HIGH-RISK SMOLDERING MYELOMA: CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE (KRD) AS INDUCTION FOLLOWED BY HDT-ASCT, CONSOLIDATION WITH KRD AND MAINTENANCE WITH RD
EHA Library, María-Victoria Mateos, 267454
GILTERITINIB SIGNIFICANTLY PROLONGS OVERALL SURVIVAL IN PATIENTS WITH FLT3-MUTATED (FLT3MUT+) RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML): RESULTS FROM THE PHASE 3 ADMIRAL TRIAL
EHA Library, Alexander Perl, 267459
PREGNANCY OUTCOME IN FEMALE PATIENTS WITH CHRONIC MYELOID LEUKEMIA WORLDWIDE: ANALYSIS OF 305 CASES OF THE EUROPEAN LEUKEMIA NET REGISTRY
EHA Library, Ekaterina Chelysheva, 267464
CLASSIFICATION OF MYELOPROLIFERATIVE NEOPLASMS BASED ON DEEP LEARNING ALGORITHMS AND MOLECULAR GENETIC MARKERS SUPPORT DISTINCTION OF CML, PV, ET, AND PMF
EHA Library, Manja Meggendorfer, 267471
NEW WHOLE GENOME ASSOCIATION SCANNING APPROACH FOR THE DISCOVERY OF HLA CLASS I-RESTRICTED MINOR HISTOCOMPATIBILITY ANTIGENS
EHA Library, Kyra Fuchs, 267473
POT1 MUTATIONS DRIVE GENOMIC INSTABILITY AND CONFER SYNTHETIC LETHALITY WITH G-QUADRUPLEX STABILIZING AGENTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
EHA Library, Saskia Rudat, 267478
INHIBITION OF C3 WITH APL-2 CONTROLS HAEMOLYSIS AND INCREASES HAEMOGLOBIN LEVELS IN SUBJECTS WITH AUTOIMMUNE HAEMOLYTIC ANAEMIA (AIHA)
EHA Library, Bruno Fattizzo, 267482
THE FUNCTIONAL RESPONSE OF IRON-RECYCLING AND INFECTION CONTROL-SPECIALIZED MACROPHAGES IS IMPAIRED BY TRANSFUSIONS AND AMELIORATED BY IRON CHELATION
EHA Library, Francesca Vinchi, 267487
AXL-RTK INHIBITION DIRECTS THE FUNCTIONAL PHENOTYPE OF CHIMERIC ANTIGEN RECEPTOR T CELLS
EHA Library, Reona Sakemura, 267492
NIVOLUMAB AND BRENTUXIMAB VEDOTIN-BASED, RESPONSE-ADAPTED TREATMENT IN PRIMARY REFRACTORY AND IN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA IN CHECKMATE 744
EHA Library, Thierry LeBlanc, 267405
CLINICAL RESPONSES AND PHARMACOKINETICS OF FULLY HUMAN BCMA TARGETING CAR T CELL THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
EHA Library, Chunrui li, 267410
A PHASE 2A STUDY OF THE LSD1 INHIBITOR IMG-7289 FOR THE TREATMENT OF MYELOFIBROSIS
EHA Library, Kristen Pettit, 267415
AZACITIDINE AND ASCORBATE INHIBIT COMPETITIVE OUTGROWTH OF HUMAN TET2-MUTANT HSPCS IN A XENOGRAFT MODEL OF PRE-LEUKEMIA
EHA Library, Yusuke Nakauchi, 267419
DYNAMIC GENETIC EVOLUTION IN MYELODYSPLASTIC SYNDROME AND THE CLINICAL IMPLICATIONS
EHA Library, Yu Jen Lin, 267424
HNRNP K LEVELS PREDICT FOR POOR CLINICAL RESPONSES IN DLBCL AND REPRESENT A NOVEL THERAPEUTIC TARGET
EHA Library, Sean Post, 267429
A FULLY HUMAN BISPECIFIC ANTIBODY FUNCTIONALLY RESCUES FACTOR VIII DEFICIENCY EX VIVO
EHA Library, Wei Wang, 267434
ALTERATION OF IRON HOMEOSTASIS IN A MOUSE MODEL OF LIVER-STAGE PLASMODIUM INFECTION
EHA Library, Francesca Vinchi, 267439
TARGETING ABERRANT DNA METHYLATION AS A NOVEL AND UNIFORM THERAPEUTIC STRATEGY FOR THE TREATMENT OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOMA
EHA Library, Morgan Thénoz, 267443
CHANGE IN CLONE SIZE DOES NOT PREDICT RISK OF MAJOR ADVERSE VASCULAR EVENTS: RESULTS FROM THE INTERNATIONAL PNH REGISTRY
EHA Library, Philippe Gustovic, 267448
GENOME-WIDE CRISPR-CAS9 SCREEN REVEALS SYNTHETIC LETHALITY OF WNT PATHWAY ACTIVATION AND ASPARAGINASE IN DRUG-RESISTANT ACUTE LEUKEMIAS
EHA Library, Laura Hinze, 267332
FRONTLINE BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY FOR STAGE 3/4 CLASSICAL HODGKIN LYMPHOMA: 3-YEAR UPDATE OF THE ECHELON-1 STUDY
EHA Library, Andrea GALLAMINI, 267403
NIVOLUMAB PLUS DOXORUBICIN, VINBLASTINE AND DACARBAZINE FOR NEWLY DIAGNOSED ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA: 2-YEAR EXTENDED FOLLOW-UP FROM COHORT D OF THE PHASE 2 CHECKMATE 205 STUDY
EHA Library, Eva Domingo-Domènech, 267404
EVALUATION OF AMG 420, AN ANTI-BCMA BISPECIFIC T-CELL ENGAGER (BITE®) IMMUNOTHERAPY, IN R/R MULTIPLE MYELOMA (MM) PATIENTS: UPDATED RESULTS OF A FIRST-IN-HUMAN (FIH) PHASE 1 DOSE ESCALATION STUDY
EHA Library, Max Topp, 267408
AVAPRITINIB, A POTENT AND SELECTIVE INHIBITOR OF KIT D816V, INDUCES COMPLETE AND DURABLE RESPONSES IN PATIENTS (PTS) WITH ADVANCED SYSTEMIC MASTOCYTOSIS (ADVSM)
EHA Library, Deepti Radia, 267413
CPI-0610, A BROMODOMAIN AND EXTRATERMINAL DOMAIN (BET) INHIBITOR, REDUCES PRO-INFLAMMATORY CYTOKINES, BONE MARROW FIBROSIS AND THE NUMBER OF TRANSFUSIONS IN MYELOFIBROSIS PATIENTS
EHA Library, Ronald Hoffman, 267414
MASS CYTOMETRY REVEAL EARLY SIGNALING RESPONSES TO INDUCTION THERAPY IN IMMUNOPHENOTYPICALLY DEFINED LEUKEMIC CELL SUBSETS THAT PREDICT SURVIVAL IN AML
EHA Library, Benedicte Tislevoll, 267418
PHASE II STUDY OF ORAL RIGOSERTIB COMBINED WITH AZACITIDINE IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES (MDS)
EHA Library, Michael E. Petrone, 267422
IMPACT OF 1ST LINE TREATMENT ON OVERALL SURVIVAL IN 1.633 PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA - A MULTINATIONAL COLLABORATIVE EFFORT COORDINATED BY THE AGMT STUDY GROUP
EHA Library, Lisa Pleyer, 267423
TNF-Α BLOCKADE CORRECTS THE MONOCYTE/MACROPHAGE IMBALANCE IN PRIMARY IMMUNE THROMBOCYTOPENIA (ITP)
EHA Library, Yajing Zhao, 267432
SAFETY AND EFFICACY OF AN ANTI-FCRN ANTIBODY, ROZANOLIXIZUMAB, IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA: INTERIM RESULTS OF A PHASE II, MULTIPLE-DOSE STUDY
EHA Library, Tadeusz Robak, 267433
IMR-687, A HIGHLY SELECTIVE PHOSPHODIESTERASE 9 INHIBITOR (PDE9I), DEMONSTRATES PRELIMINARY EVIDENCE OF ACTIVITY ON RED AND WHITE CELL BIOMARKERS IN A PH-2A INTERIM ANALYSIS
EHA Library, Biree Andemariam, 267437
TCD IMPLEMENTATION RATES AND RESULTS IN THE MODERN ERA OF SICKLE CELL ANEMIA: RESULTS FROM THE DISPLACE STUDY
EHA Library, Julie Kanter, 267438
ONE-YEAR EFFICACY OF RAVULIZUMAB (ALXN1210) IN ADULT PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA NAIVE TO COMPLEMENT INHIBITORS
EHA Library, Hubert Schrezenmeier, 267446
A PHASE 2 OPEN-LABEL PROOF OF CONCEPT STUDY OF THE ORAL, SMALL MOLECULE FACTOR D INHIBITOR, ACH-4471, IN UNTREATED PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
EHA Library, Peter Browett, 267447

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings